Page 2 - Molecular Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Development Today - Breaking & Trending Today

FDA Approves Pozelimab (Veopoz) as First Treatment for CHAPLE Disease

Published: August 18, 2023

The FDA approval of pozelimab (Veopoz) makes it the first and only treatment indicated for children and adults with CHAPLE disease.

Source: hcplive.com

Related Topics:

Michael LenardoGeorged YancopoulosMolecular Development Of The Immune System SectionNational Institute Of AllergyDrug AdministrationNational Institutes Of HealthDrug Administration Us FoodClinical Genomics ProgramMolecular DevelopmentImmune System SectionNational InstituteInfectious DiseaseNational InstitutesRare DiseaseChaple DiseaseSfda NewsPozelimab Bbfg